Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure.
According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest to help blood flow throughout the body — later in their disease progression when compared to white patients, ultimately resulting in worse health outcomes.
Get the full story at our sister site, Medical Design & Outsourcing.